Big Cypress Acquisition
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch BCYP and buy or sell other stocks, ETFs, and their options commission-free!About BCYP
SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company, which engages in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. The firm produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases.
CEOSamuel J. Reich
CEOSamuel J. Reich
Employees63
Employees63
HeadquartersMiami Beach, Florida
HeadquartersMiami Beach, Florida
Founded2014
Founded2014
Employees63
Employees63
BCYP Key Statistics
Market cap283.06M
Market cap283.06M
Price-Earnings ratio-1.23
Price-Earnings ratio-1.23
Dividend yield—
Dividend yield—
Average volume240.25K
Average volume240.25K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$6.60
52 Week high$6.60
52 Week low$1.00
52 Week low$1.00
Stock Snapshot
The current Big Cypress Acquisition(BCYP) stock price is $5.96, with a market capitalization of 283.06M. The stock trades at a price-to-earnings (P/E) ratio of -1.23.
During the trading day, Big Cypress Acquisition(BCYP) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Big Cypress Acquisition(BCYP) stock has reached 0, versus its average volume of 240.25K.
The stock's 52-week range extends from a low of $1.00 to a high of $6.60.
The stock's 52-week range extends from a low of $1.00 to a high of $6.60.
People also own
Based on the portfolios of people who own BCYP. This list is generated using Robinhood data, and it’s not a recommendation.